Time limited offer for new users ▶ Get up to 3 months free

Serving leading biopharmaceutical companies globally:

Colorcon
AstraZeneca
McKinsey
Boehringer Ingelheim
Dow
Express Scripts

Last Updated: January 27, 2023

Torsemide - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What are the generic drug sources for torsemide and what is the scope of patent protection?

Torsemide is the generic ingredient in three branded drugs marketed by Roche, Am Regent, West-ward Pharms Int, Mylan Speciality Lp, Sarfe Pharms, Aurobindo Pharma, Corepharma, Hetero Labs Ltd Iii, Hikma, Pliva Pharm Ind, Strides Pharma, Sun Pharm Inds, and Teva, and is included in fourteen NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

Torsemide has two patent family members in two countries.

There are sixteen drug master file entries for torsemide. Fifteen suppliers are listed for this compound.

Drug Prices for torsemide

See drug prices for torsemide

Drug Sales Revenue Trends for torsemide

See drug sales revenues for torsemide

Recent Clinical Trials for torsemide

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Assiut UniversityPhase 4
Yale UniversityPhase 3
National Heart, Lung, and Blood Institute (NHLBI)Phase 3

See all torsemide clinical trials

Pharmacology for torsemide

US Patents and Regulatory Information for torsemide

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hikma TORSEMIDE torsemide TABLET;ORAL 076943-002 Mar 1, 2005 AB RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Strides Pharma TORSEMIDE torsemide TABLET;ORAL 076226-001 May 27, 2003 AB RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Sarfe Pharms SOAANZ torsemide TABLET;ORAL 213218-003 Nov 17, 2021 RX Yes No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Sun Pharm Inds TORSEMIDE torsemide TABLET;ORAL 078478-002 Feb 26, 2008 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Hetero Labs Ltd Iii TORSEMIDE torsemide TABLET;ORAL 079234-003 Jan 27, 2009 AB RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Teva TORSEMIDE torsemide TABLET;ORAL 076110-003 May 14, 2002 AB RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
West-ward Pharms Int TORSEMIDE torsemide INJECTABLE;INJECTION 078007-002 Jun 11, 2008 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for torsemide

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Johnson and Johnson
McKesson
McKinsey
Baxter
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.